Literature DB >> 26443011

Small-Molecule Allosteric Modulators of the Protein Kinase PDK1 from Structure-Based Docking.

T Justin Rettenmaier1,2, Hao Fan2,3,4, Joel Karpiak1,2, Allison Doak2, Andrej Sali5, Brian K Shoichet2, James A Wells2,6.   

Abstract

Finding small molecules that target allosteric sites remains a grand challenge for ligand discovery. In the protein kinase field, only a handful of highly selective allosteric modulators have been found. Thus, more general methods are needed to discover allosteric modulators for additional kinases. Here, we use virtual screening against an ensemble of both crystal structures and comparative models to identify ligands for an allosteric peptide-binding site on the protein kinase PDK1 (the PIF pocket). We optimized these ligands through an analog-by-catalog search that yielded compound 4, which binds to PDK1 with 8 μM affinity. We confirmed the docking poses by determining a crystal structure of PDK1 in complex with 4. Because the PIF pocket appears to be a recurring structural feature of the kinase fold, known generally as the helix αC patch, this approach may enable the discovery of allosteric modulators for other kinases.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26443011      PMCID: PMC5099076          DOI: 10.1021/acs.jmedchem.5b01216

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  35 in total

1.  Structure-based ligand discovery for the protein-protein interface of chemokine receptor CXCR4.

Authors:  Michael M Mysinger; Dahlia R Weiss; Joshua J Ziarek; Stéphanie Gravel; Allison K Doak; Joel Karpiak; Nikolaus Heveker; Brian K Shoichet; Brian F Volkman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-19       Impact factor: 11.205

2.  Rapid context-dependent ligand desolvation in molecular docking.

Authors:  Michael M Mysinger; Brian K Shoichet
Journal:  J Chem Inf Model       Date:  2010-09-27       Impact factor: 4.956

3.  Structure and allosteric effects of low-molecular-weight activators on the protein kinase PDK1.

Authors:  Valerie Hindie; Adriana Stroba; Hua Zhang; Laura A Lopez-Garcia; Leila Idrissova; Stefan Zeuzem; Daniel Hirschberg; Francis Schaeffer; Thomas J D Jørgensen; Matthias Engel; Pedro M Alzari; Ricardo M Biondi
Journal:  Nat Chem Biol       Date:  2009-08-30       Impact factor: 15.040

4.  Substrate-selective inhibition of protein kinase PDK1 by small compounds that bind to the PIF-pocket allosteric docking site.

Authors:  Katrien Busschots; Laura A Lopez-Garcia; Carmen Lammi; Adriana Stroba; Stefan Zeuzem; Albrecht Piiper; Pedro M Alzari; Sonja Neimanis; Jose M Arencibia; Matthias Engel; Jörg O Schulze; Ricardo M Biondi
Journal:  Chem Biol       Date:  2012-09-21

5.  Discovery of PDK1 kinase inhibitors with a novel mechanism of action by ultrahigh throughput screening.

Authors:  Ekaterina V Bobkova; Michael J Weber; Zangwei Xu; Yan-Ling Zhang; Joon Jung; Peter Blume-Jensen; Alan Northrup; Priya Kunapuli; Jannik N Andersen; Ilona Kariv
Journal:  J Biol Chem       Date:  2010-04-12       Impact factor: 5.157

6.  Characterization of GSK2334470, a novel and highly specific inhibitor of PDK1.

Authors:  Ayaz Najafov; Eeva M Sommer; Jeffrey M Axten; M Phillip Deyoung; Dario R Alessi
Journal:  Biochem J       Date:  2011-01-15       Impact factor: 3.857

7.  Towards automated crystallographic structure refinement with phenix.refine.

Authors:  Pavel V Afonine; Ralf W Grosse-Kunstleve; Nathaniel Echols; Jeffrey J Headd; Nigel W Moriarty; Marat Mustyakimov; Thomas C Terwilliger; Alexandre Urzhumtsev; Peter H Zwart; Paul D Adams
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2012-03-16

8.  Incorporation of protein flexibility and conformational energy penalties in docking screens to improve ligand discovery.

Authors:  Marcus Fischer; Ryan G Coleman; James S Fraser; Brian K Shoichet
Journal:  Nat Chem       Date:  2014-05-25       Impact factor: 24.427

9.  MolProbity: all-atom structure validation for macromolecular crystallography.

Authors:  Vincent B Chen; W Bryan Arendall; Jeffrey J Headd; Daniel A Keedy; Robert M Immormino; Gary J Kapral; Laura W Murray; Jane S Richardson; David C Richardson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  6 in total

Review 1.  Docking Screens for Novel Ligands Conferring New Biology.

Authors:  John J Irwin; Brian K Shoichet
Journal:  J Med Chem       Date:  2016-03-15       Impact factor: 7.446

2.  A computational approach yields selective inhibitors of human excitatory amino acid transporter 2 (EAAT2).

Authors:  Kelly L Damm-Ganamet; Marie-Laure Rives; Alan D Wickenden; Heather M McAllister; Taraneh Mirzadegan
Journal:  J Biol Chem       Date:  2020-02-20       Impact factor: 5.157

3.  The Development of Target-Specific Pose Filter Ensembles To Boost Ligand Enrichment for Structure-Based Virtual Screening.

Authors:  Jie Xia; Jui-Hua Hsieh; Huabin Hu; Song Wu; Xiang Simon Wang
Journal:  J Chem Inf Model       Date:  2017-06-01       Impact factor: 4.956

4.  Structure-based discovery of potentially active semiochemicals for Cydia pomonella (L.).

Authors:  Jiyuan Liu; Zhen Tian; Yalin Zhang
Journal:  Sci Rep       Date:  2016-10-06       Impact factor: 4.379

Review 5.  In silico Methods for Design of Kinase Inhibitors as Anticancer Drugs.

Authors:  Zarko Gagic; Dusan Ruzic; Nemanja Djokovic; Teodora Djikic; Katarina Nikolic
Journal:  Front Chem       Date:  2020-01-08       Impact factor: 5.221

6.  Indoprofen prevents muscle wasting in aged mice through activation of PDK1/AKT pathway.

Authors:  Hyebeen Kim; Sung Chun Cho; Hyeon-Ju Jeong; Hye-Young Lee; Myong-Ho Jeong; Jung-Hoon Pyun; Dongryeol Ryu; MinSeok Kim; Young-Sam Lee; Minseok S Kim; Sang Chul Park; Yun-Il Lee; Jong-Sun Kang
Journal:  J Cachexia Sarcopenia Muscle       Date:  2020-02-25       Impact factor: 12.910

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.